Washington, March 4 (IANS) The U.S. International Trade Commission (USITC) has received a complaint alleging that biosimilar versions of the cancer drug pertuzumab imported into the United States violate U.S. trade law. Several entities of India’s largest biopharmaceutical company, Biocon, have been named as respondents.The notice was published in the Federal Register. It said the complaint was filed by the world’s top biotech company, Genentech, on February 27, 2026.“The Commiss…
Trending
- Dose (2026) Movie Review: A Gripping Medical Thriller With a Powerful Core Concept
- Teesri Begum (2026) Review: A Bold Social Drama That Shines a Light on Deception and Resilience
- Purushaha Review: A Heartwarming Family Comedy That Keeps You Laughing
- Deool Band 2 Review: A Heartfelt Devotional Drama That Speaks to the Soul
- Ramani Kalyanam Review (2026) – A Heartfelt Tale of Love, Courage & Resilience
- Ugly Story (2026) Review: A Raw and Brave Telugu Film That Hits Hard
- War of Shera (Shera) Review: Parmish Verma Delivers a Powerful Revenge Drama That Hits All the Right Notes
- Desi Bling Review: Dubai’s Richest Indian Circles Bring Drama, Diamonds, and Addictive Chaos to Netflix
